Inventor · disambiguated record
Paula Ann Boriack-Sjodin
Also filed as: BORIACK-SJODIN PAULA · BORIACK-SJODIN PAULA A · BORIACK-SJODIN PAULA ANN
28 granted patents·15 pending applications·607 citations·filing 2003–2021
97Inventor score
Top patents by PatentIndex Score
43 records- 0199US9475776B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Oct 25, 2016·32 cites·9 claims
- 0299US9365519B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Jun 14, 2016·34 cites·39 claims
- 0399US9023883B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted May 5, 2015·46 cites·20 claims
- 0499US8993555B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 31, 2015·50 cites·4 claims
- 0598US9675614B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Jun 13, 2017·17 cites·23 claims
- 0698US9604930B2Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 28, 2017·21 cites·35 claims
- 0798US8940726B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Jan 27, 2015·47 cites·22 claims
- 0896US9868703B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Jan 16, 2018·15 cites·2 claims
- 0996US9732041B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Aug 15, 2017·17 cites·9 claims
- 1096US9447079B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 20, 2016·38 cites·13 claims
- 1196US9346761B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted May 24, 2016·38 cites·36 claims
- 1296US9266836B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Feb 23, 2016·35 cites·28 claims
- 1396US9221794B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Dec 29, 2015·40 cites·17 claims
- 1496US8952026B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Feb 10, 2015·47 cites·20 claims
- 1595US9765068B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Sep 19, 2017·14 cites·27 claims
- 1695US9732072B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Aug 15, 2017·16 cites·19 claims
- 1794US10391089B2PRMT5 inhibitors and uses therofEPIZYME INC·Filed 2017·Granted Aug 27, 2019·5 cites·19 claims
- 1894US10307413B2Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Jun 4, 2019·5 cites·39 claims
- 1993US9745291B2PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereofEPIZYME INC·Filed 2013·Granted Aug 29, 2017·14 cites·13 claims
- 2092US9776972B2Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Oct 3, 2017·14 cites·31 claims
- 2192US7442370B2Polymer conjugates of mutated neublastinBIOGEN IDEC INC·Filed 2003·Granted Oct 28, 2008·35 cites·68 claims
- 2291US10227307B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Mar 12, 2019·6 cites·18 claims
- 2391US10039748B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Aug 7, 2018·9 cites·13 claims
- 2486US10980794B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2019·Granted Apr 20, 2021·1 cites·20 claims
- 2585US8119114B2Polymer conjugates of mutated neublastinSAH DINAH WEN-YEE·Filed 2008·Granted Feb 21, 2012·3 cites·60 claims
- 2677US10118918B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Nov 6, 2018·2 cites·23 claims
- 2777US2021308121A1Prmt5 inhibitors and uses thereofEPIZYME INC·Filed 2021·Application pending·0 cites
- 2874US2019343826A1Tetrahydro- and dihydro-isoquinoline prmt5 inhibitors and uses thereofEPIZYME INC·Filed 2019·Application pending·0 cites
- 2969US7691865B2Pyrazolopyridines and methods of making and using the sameBIOGEN IDEC INC·Filed 2003·Granted Apr 6, 2010·5 cites·11 claims
- 3068US2018098987A1PRMT5 Inhibitors and Uses ThereofEPIZYME INC·Filed 2017·Application pending·0 cites
- 3167US10653693B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted May 19, 2020·1 cites·17 claims
- 3261US2018162847A1Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereofEPIZYME INC·Filed 2017·Application pending·0 cites
- 3359US2018237397A1Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2017·Application pending·0 cites
- 3457US2019022064A1PRMT1 Inhibitors and Uses ThereofEPIZYME INC·Filed 2018·Application pending·0 cites
- 3552US2019077795A1Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2018·Application pending·0 cites
- 3649US2023027361A1Mettl3 modulatorsACCENT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3748US2022372040A1Mettl3 modulatorsACCENT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3848US2010056505A1Substituted PyrazalonesBIOGEN IDEC INC·Filed 2006·Application pending·0 cites
- 3947US2019083482A1Prmt5 inhibitors and uses thereofDUNCAN KENNETH W·Filed 2017·Application pending·0 cites
- 4045US2015344457A1Methods of inhibiting prmt5EPIZYME INC·Filed 2013·Application pending·0 cites
- 4143US2006264440A1Pyrazoles and methods of making and using the sameBIOGEN IDEC INC·Filed 2004·Application pending·0 cites
- 4243US2017283400A1Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2015·Application pending·0 cites
- 4341US2006135517A1Imidazolopyridines and methods of making and using the sameLEE WEN-CHERNG·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paula Ann Boriack-Sjodin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →